A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
Main Authors: | Kelly, C, Folgori, A, Capone, S, Stafford, E, O'Donnell, D, Gantlett, K, Collier, J, Brown, A, Huddart, R, Humphreys, I, Kurioka, A, Townsend, R, Swadling, L, Ammendola, V, Colloca, S, Naddeo, M, Siani, L, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P, Barnes, E |
---|---|
Format: | Conference item |
Published: |
2011
|
Similar Items
-
IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
by: Kelly, C, et al.
Published: (2012) -
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Barnes, E, et al.
Published: (2011) -
A highly immunogenic novel genetic vaccine against HCV
by: Del Sorbo, M, et al.
Published: (2012) -
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
by: Swadling, L, et al.
Published: (2014) -
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
by: Folgori, A, et al.
Published: (2009)